Nanobiotix

Nanobiotix is a late stage clinical company pioneering nanomedicine for more than a decade. We intend to significantly change the outcomes for cancer patients following a different path than other Pharma or Biotech companies: a new way to treat patients thanks to nanophysics at the heart of the cell. Nanobiotix operates worldwide from the headquarters based in Paris, France and affiliate office in Cambridge, MA, USA. Nanobiotix has partnered with PharmaEngine for clinical development and commercialization of NBTXR3 in Asia. We develop first-in-class products with the aim to provide a maximum benefit with a minimum change in the medical practice in order to limit the hurdle of healthcare cost.
Type
Public
HQ
Paris, FR
Founded
2003
Size (employees)
60 (est)
Nanobiotix was founded in 2003 and is headquartered in Paris, FR

Nanobiotix Office Locations

Nanobiotix has offices in Paris and Cambridge
Paris, FR (HQ)
60 Rue De Wattignies
Cambridge, US
210 Broadway

Nanobiotix Data and Metrics

Nanobiotix Financial Metrics

EUR

Market capitalization (23-Jun-2017)

313.8 m

Closing share price (23-Jun-2017)

20.1
Nanobiotix's current market capitalization is €313.8 m.

Nanobiotix Market Value History

Nanobiotix Online and Social Media Presence

Nanobiotix Company Life and Culture

You may also be interested in